dipyridamole has been researched along with Aneurysm, Coronary in 13 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The long-term outcome of coronary aneurysm after Kawasaki disease was investigated using dipyridamole-loading angiography in 33 children with coronary aneurysms after Kawasaki disease." | 7.70 | Morphologic and functional assessment of coronary aneurysm after Kawasaki disease by repeated dipyridamole-loading coronary angiography. ( Shinohara, M; Sone, K; Tomomasa, T, 1998) |
| "Positron emission tomography and H2(15)O were used to characterize regional myocardial blood flow and distribution at rest and in response to dipyridamole in children with Kawasaki disease but without angiographic evidence of coronary stenosis." | 7.69 | Assessment of effects of intravenous dipyridamole on regional myocardial perfusion in children with Kawasaki disease without angiographic evidence of coronary stenosis using positron emission tomography and H2(15)O. ( Hamaoka, K; Oda, Y; Ohmochi, Y; Onouchi, Z, 1995) |
| "The authors evaluated the distensibility of the coronary arterial wall by pharmacoangiography with intravenous administration of dipyridamole in 38 patients with Kawasaki disease." | 7.67 | Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall. ( Hirano, T; Ito, T; Matsumura, K; Okuda, Y; Takeda, K; Yamaguchi, N, 1988) |
| "The long-term outcome of coronary aneurysm after Kawasaki disease was investigated using dipyridamole-loading angiography in 33 children with coronary aneurysms after Kawasaki disease." | 3.70 | Morphologic and functional assessment of coronary aneurysm after Kawasaki disease by repeated dipyridamole-loading coronary angiography. ( Shinohara, M; Sone, K; Tomomasa, T, 1998) |
| "Positron emission tomography and H2(15)O were used to characterize regional myocardial blood flow and distribution at rest and in response to dipyridamole in children with Kawasaki disease but without angiographic evidence of coronary stenosis." | 3.69 | Assessment of effects of intravenous dipyridamole on regional myocardial perfusion in children with Kawasaki disease without angiographic evidence of coronary stenosis using positron emission tomography and H2(15)O. ( Hamaoka, K; Oda, Y; Ohmochi, Y; Onouchi, Z, 1995) |
| "This study determined the feasibility and accuracy of quantitative 201Tl myocardial single-photon emission computed tomography (SPECT) after dipyridamole infusion to detect coronary obstructive lesions in children with Kawasaki disease." | 3.67 | Detection of coronary artery stenosis in children with Kawasaki disease. Usefulness of pharmacologic stress 201Tl myocardial tomography. ( Hiroe, M; Kondo, C; Nakanishi, T; Takao, A, 1989) |
| "The authors evaluated the distensibility of the coronary arterial wall by pharmacoangiography with intravenous administration of dipyridamole in 38 patients with Kawasaki disease." | 3.67 | Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall. ( Hirano, T; Ito, T; Matsumura, K; Okuda, Y; Takeda, K; Yamaguchi, N, 1988) |
| "Personal experience in 41 children with Kawasaki disease is reported." | 1.31 | [Cardiac involvement in Kawasaki disease. Our experience]. ( Barone, P; Betta, P; Distefano, G; Falsaperla, R; Marletta, M; Mattia, C; Sciacca, P; Tornambene, G, 2001) |
| "Aspirin was used in most patients often in conjunction with dipyridamole and from 1986 intravenous immunoglobulin was given routinely to those patients seen early in the illness." | 1.28 | Clinical aspects of 100 patients with Kawasaki disease. ( Dillon, MJ; Levin, M; Suzuki, A; Tizard, EJ, 1991) |
| " DIP was infused at a dosage of 0." | 1.28 | Dipyridamole-induced ischemia in a child with jeopardized collaterals after Kawasaki syndrome. ( Matsuo, N; Matsuura, H; Saji, T; Umezawa, T; Yabe, Y; Yamamoto, S, 1990) |
| "The diagnosis of Kawasaki disease and echocardiographic evaluation of the coronary arteries should be considered in young infants with prolonged fever of unknown origin." | 1.27 | Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. ( Burns, JC; Glodé, MP; Leung, DY; Newburger, JW; Toews, WH; Wiggins, JW; Wilson, H, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muneuchi, J | 1 |
| Ishimura, M | 1 |
| Takada, H | 1 |
| Hoshina, T | 1 |
| Utsunomiya, R | 1 |
| Ikeda, K | 1 |
| Yamaguchi, K | 1 |
| Ohga, S | 1 |
| Kusuhara, K | 1 |
| Hara, T | 1 |
| Lee, PC | 1 |
| Shiau, YC | 1 |
| Fu, YC | 1 |
| Kao, A | 1 |
| Lin, CC | 1 |
| Lee, CC | 1 |
| Ohmochi, Y | 1 |
| Onouchi, Z | 1 |
| Oda, Y | 1 |
| Hamaoka, K | 1 |
| Kondo, C | 2 |
| Nakanishi, T | 2 |
| Sonobe, T | 1 |
| Tatara, K | 1 |
| Momma, K | 1 |
| Kusakabe, K | 1 |
| Shinohara, M | 2 |
| Sone, K | 2 |
| Tomomasa, T | 2 |
| Morikawa, A | 1 |
| Sciacca, P | 1 |
| Falsaperla, R | 1 |
| Barone, P | 1 |
| Tornambene, G | 1 |
| Mattia, C | 1 |
| Marletta, M | 1 |
| Betta, P | 1 |
| Distefano, G | 1 |
| Houly, SR | 1 |
| Houly, RS | 1 |
| Oliveira, CC | 1 |
| de Albuquerque, PF | 1 |
| Coutinho, MA | 1 |
| Santos, RJ | 1 |
| Lira, N | 1 |
| Lira Neto, FS | 1 |
| Tizard, EJ | 1 |
| Suzuki, A | 1 |
| Levin, M | 1 |
| Dillon, MJ | 1 |
| Yamamoto, S | 1 |
| Matsuura, H | 1 |
| Umezawa, T | 1 |
| Saji, T | 1 |
| Matsuo, N | 1 |
| Yabe, Y | 1 |
| Hiroe, M | 1 |
| Takao, A | 1 |
| Matsumura, K | 1 |
| Okuda, Y | 1 |
| Ito, T | 1 |
| Hirano, T | 1 |
| Takeda, K | 1 |
| Yamaguchi, N | 1 |
| Burns, JC | 1 |
| Wiggins, JW | 1 |
| Toews, WH | 1 |
| Newburger, JW | 1 |
| Leung, DY | 1 |
| Wilson, H | 1 |
| Glodé, MP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000520] | Phase 2 | 0 participants | Interventional | 1985-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 other studies available for dipyridamole and Aneurysm, Coronary
| Article | Year |
|---|---|
Incomplete Kawasaki disease in a patient with chronic granulomatous disease.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Coronary Angiography; Dipyridamole; Follow-Up Studies; | 2010 |
Discordance between dipyridamole technetium-99m-sestamibi myocardial perfusion single photon emission computed tomography and two-dimensional echocardiography in Kawasaki disease--a preliminary report.
Topics: Adolescent; Child; Child, Preschool; Coronary Aneurysm; Coronary Disease; Dipyridamole; Echocardiogr | 2002 |
Assessment of effects of intravenous dipyridamole on regional myocardial perfusion in children with Kawasaki disease without angiographic evidence of coronary stenosis using positron emission tomography and H2(15)O.
Topics: Adolescent; Adult; Coronary Aneurysm; Coronary Angiography; Coronary Circulation; Dipyridamole; Elec | 1995 |
Scintigraphic monitoring of coronary artery occlusion due to Kawasaki disease.
Topics: Coronary Aneurysm; Coronary Angiography; Coronary Disease; Coronary Vessels; Dipyridamole; Humans; M | 1993 |
Morphologic and functional assessment of coronary aneurysm after Kawasaki disease by repeated dipyridamole-loading coronary angiography.
Topics: Adolescent; Cardiac Catheterization; Child; Child, Preschool; Coronary Aneurysm; Coronary Angiograph | 1998 |
Corticosteroids in the treatment of the acute phase of Kawasaki disease.
Topics: Acute Disease; Aspirin; Child, Preschool; Coronary Aneurysm; Dipyridamole; Drug Therapy, Combination | 1999 |
[Cardiac involvement in Kawasaki disease. Our experience].
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Aneurysm; | 2001 |
[Regression of coronary artery aneurysm in a patient with Kawasaki's disease].
Topics: Aspirin; Coronary Aneurysm; Dipyridamole; Echocardiography; Female; Humans; Infant; Mucocutaneous Ly | 1991 |
Clinical aspects of 100 patients with Kawasaki disease.
Topics: Aspirin; Blood Sedimentation; Child; Child, Preschool; Coronary Aneurysm; Coronary Disease; Dipyrida | 1991 |
Dipyridamole-induced ischemia in a child with jeopardized collaterals after Kawasaki syndrome.
Topics: Child, Preschool; Collateral Circulation; Coronary Aneurysm; Coronary Circulation; Coronary Disease; | 1990 |
Detection of coronary artery stenosis in children with Kawasaki disease. Usefulness of pharmacologic stress 201Tl myocardial tomography.
Topics: Adolescent; Child; Child, Preschool; Color; Constriction, Pathologic; Coronary Aneurysm; Coronary An | 1989 |
Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall.
Topics: Acute Disease; Adolescent; Blood Pressure; Child; Child, Preschool; Cineangiography; Coronary Aneury | 1988 |
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age.
Topics: Aspirin; Coronary Aneurysm; Dipyridamole; Drug Therapy, Combination; Echocardiography; Electrocardio | 1986 |